齐齐哈尔医学院学报
齊齊哈爾醫學院學報
제제합이의학원학보
Journal of Qiqihar University of Medicine
2015年
30期
4574-4575
,共2页
朱彦霞%姜士军%蒋燕玲%张竖%徐强
硃彥霞%薑士軍%蔣燕玲%張豎%徐彊
주언하%강사군%장연령%장수%서강
羟苯磺酸钙%视网膜静脉阻塞%非缺血型
羥苯磺痠鈣%視網膜靜脈阻塞%非缺血型
간분광산개%시망막정맥조새%비결혈형
Calcium dobesilate%Retinal vein occlusion%Non-ischemic
目的 探讨羟苯磺酸钙治疗非缺血型视网膜静脉阻塞( retinal vein occlusion,RVO)的临床疗效. 方法 对非缺血型RVO患者46例随机分为治疗组和对照组. 对照组21例21眼,给予丹参静滴及复方血栓通胶囊口服,连续用药观察30天. 治疗组在对照组基础上加用羟苯磺酸钙. 观察治疗前后视力、眼底病的改变、视野和视网膜电图. 结果 治疗组最佳矫正视力提高行数显著高于对照组(P <0.05).治疗组与对照组治疗后视野比较有统计学差异(P<0.05). 视网膜电图b波振幅治疗组提高高于对照组( P<0.05). 结论 羟苯磺酸钙在治疗非缺血性视网膜静脉阻塞中具有明显的临床疗效.
目的 探討羥苯磺痠鈣治療非缺血型視網膜靜脈阻塞( retinal vein occlusion,RVO)的臨床療效. 方法 對非缺血型RVO患者46例隨機分為治療組和對照組. 對照組21例21眼,給予丹參靜滴及複方血栓通膠囊口服,連續用藥觀察30天. 治療組在對照組基礎上加用羥苯磺痠鈣. 觀察治療前後視力、眼底病的改變、視野和視網膜電圖. 結果 治療組最佳矯正視力提高行數顯著高于對照組(P <0.05).治療組與對照組治療後視野比較有統計學差異(P<0.05). 視網膜電圖b波振幅治療組提高高于對照組( P<0.05). 結論 羥苯磺痠鈣在治療非缺血性視網膜靜脈阻塞中具有明顯的臨床療效.
목적 탐토간분광산개치료비결혈형시망막정맥조새( retinal vein occlusion,RVO)적림상료효. 방법 대비결혈형RVO환자46례수궤분위치료조화대조조. 대조조21례21안,급여단삼정적급복방혈전통효낭구복,련속용약관찰30천. 치료조재대조조기출상가용간분광산개. 관찰치료전후시력、안저병적개변、시야화시망막전도. 결과 치료조최가교정시력제고행수현저고우대조조(P <0.05).치료조여대조조치료후시야비교유통계학차이(P<0.05). 시망막전도b파진폭치료조제고고우대조조( P<0.05). 결론 간분광산개재치료비결혈성시망막정맥조새중구유명현적림상료효.
Objective To study the therapeutic efficacy of calcium dobesilate in treating non-ischemic retinal vein occlusion.Methods 48 cases of non-ischemic retinal vein occlusion were randomly divided into two groups.21 eyes enrolled in control group were treated by Danshen injection and Fufang Xueshuantong capsule for 30 days.27 eyes enrolled in treatment group were treated by Danshen injection and Fufang Xueshuantong capsule with calcium dobesilate .The vision, vision field, electroretinogram and eye fundus were observed before 30 days after treatment.Results The improvement of best-corrected visual acuity in treatment group was much better than that in control group with statistical difference (P<0.05).The visual field of two groups after treatment has significant difference (P<0.05).There was statistical difference between treatment group and control group in the amplitude of wave b (P<0.05).Conclusions Calcium dobesilate has significant clinical effect in treating non-ischemic retinal vein occlusion.